-
Ganeshan Guruswamy commented on the post, Phase III Trial to Study Combination of Genentech's Actemra, Gilead's Remdesivir vs. Severe COVID-19 2 years, 1 month ago
Why are we taking so much time to even start a clinical trial? Agreed in normal times we want to come up with proposals and evaluate them before starting a clinical trial. But these are not normal times and people are dying. Looks like the industry is only interested in studying. Even one talks about studying and then they plans for the studies…[Read more]
Home Ganeshan Guruswamy
